Remarkable Synergy When Combining EZH2 Inhibitors with YM155 Is H3K27me3-Independent
Jun Yang(St. Jude Children's Research Hospital), Andrew M. Davidoff(St. Jude Children's Research Hospital)
Cited by 2
Related Papers
Long-Term Safety and Efficacy of Factor IX Gene Therapy in Hemophilia B
|New England Journal of Medicine|2014|1.2k
Estrogen receptor-α directly regulates the hypoxia-inducible factor 1 pathway associated with antiestrogen response in breast cancer
|Proceedings of the National Academy of Sciences|2015|134
Histone lysine demethylase 4 family proteins maintain the transcriptional program and adrenergic cellular state of MYCN-amplified neuroblastoma
|Cell Reports Medicine|2024|9
Geldanamycin inhibits Jumonji histone lysine demethylase KDM4 and targets chimeric transcription factor PAX3-FOXO1
|bioRxiv (Cold Spring Harbor Laboratory)|2019|0